Sebastien Latapie

Sebastien Latapie is a Principal at AVANT BIO, where he focuses on healthcare technology and life sciences venture capital investments. Previously, he served as a Principal at Dynamk Capital and worked as an Associate at Northzone, targeting machine learning startups within the life sciences sector. Before entering venture capital, Latapie spent over eight years at the intersection of science and business, including a tenure as a Manager at New Markets Advisors advising Fortune 500 pharmaceutical and medtech companies. He has held Board Observer roles at Alpenglow Biosciences, Curi Bio, and Lucid Scientific, and earned an MBA from Columbia Business School alongside a Master of Science in Biochemistry from McGill University. His current focus centers on leveraging his scientific expertise to identify and scale early-stage companies advancing artificial intelligence and industrial technologies in healthcare.